If it is worth doing - it is worth doing well

Welcome to BLIPS 8™ for the Renaissance Study Sponsored by ADS-Limathon Limited

The BLIPS software program has been iteratively designed and developed by ADS-Limathon in collaboration with the British Isles Lupus Assessment Group (BILAG) . BLIPS is the only BILAG scoring system validated and endorsed by the BILAG Group, and ADS-Limathon are the exclusive licensors of BILAG for commercial studies.

BLIPS™ was originally developed by ADS-Limathon as a desktop software application in 1995. It has been in constant use for over 20 years and now hosts BILAG data going back almost 30 years. In 2015 we were proud to introduce the latest version - BLIPS 8 Suite™ - a modular suite of BLIPS applications designed to monitor and assess lupus patients at regular assessments.

Nowadays, the BLIPS 8 Service is hosted on the latest high availability technology with server replication, using the latest dual processor servers, with RAID arrays of solid state drives for speed, daily backups for data security, and offsite backups for disaster recovery.

The BLIPS 8™ Software uses HTML5 technology for maximum browser compatibility ensuring that you will not require any browser plug-ins or PC installation. BLIPS 8™ comprises the following modules:

  • BLIPS Certify™ - Standardising assessments through training and certification
  • BLIPS Entry™  - Simplifying Data Entry and Scoring
  • BLIPS Quality™ -  Automated edit checks ensuring data consistency and quality
  • BLIPS Responder™ -  Real time generation of SRI and BICLA responders
  • BLIPS Analysis™ - Push button trend analysis and graphing
  • BLIPS Dashboard™ -  Providing study overview, and user permission management
  • BLIPS Extract™  - custom, scheduled and ad-hoc data exports

BLIPS 8™ Software for Renaissance features:

  • BILAG Index, the gold standard lupus activity assessment
  • SLEDAI 2K, a disease activity index with subtle differences to SELENA SLEDAI
  • LupusQOL, a quality of life index, specifically validated for lupus patients.
  • SRI-4, a responder index generated from BILAG and SLEDAI assessments

Individual studies can choose from a range of over 40 different disease indices covering lupus, arthritis, myositis, fatigue to name a few.

BLIPS has been the number one choice of pharmaceutical studies evaluating the performance and safety of new lupus treatments for the last 10 years and in number one choice in lupus clinics for 20 years. If your clinic, research group or  national lupus registry would like to use the latest version, BLIPS 8™, to monitor ALL the patients at your clinic, please contact ADS-Limathon and we will be pleased to discuss. BLIPS 8™ now has over 40 indices available to tailor to your requirements.